Phase II in-human dose escalation study of the optical molecular imaging tracer bevacizumab-800cw for molecular fluorescence guided surgery in primary breast cancer patients

G. M. van Dam, M. Koller, S. Q. Qiu, M. D. Linssen, J. de Vries, L. Jansen, W. Kelder, J. S. de Jong, A. Jorritsma-Smit, B. van der Vegt, D. J. Robinson, W. B. Nagengast

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)P4-01-01
Number of pages3
JournalCancer Research
Issue number4 supp
Publication statusPublished - Feb-2017
EventSan Antonio Breast Cancer Symposium - San Antonio
Duration: 6-Dec-201610-Dec-2016

Cite this